⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41922 | 1.00 | — | — | |
| SCHEMBL2755195 | 1.00 | — | — | |
| SCHEMBL624856 | 0.94 | — | — | |
| SCHEMBL16589433 | 0.80 | — | — | |
| SCHEMBL19335129 | 0.80 | — | — | |
| SCHEMBL24505 | 0.80 | — | — | |
| SCHEMBL5250 | 0.77 | — | — | |
| SCHEMBL330158 | 0.77 | — | — | |
| SCHEMBL28874112 | 0.76 | — | — | |
| Lithium SCHEMBL30106431 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022119899-A1 | A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME BC1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN | SHIONOGI & CO., LTD. (JP) | 2022-06-09 | — | — | WO | disclosed |
| US-8389702-B2 | Multi-oligomeric or multi-polymeric compositions comprising labeled moieties and binding partners | ENZO LIFE SCIENCES, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| WO-2008052861-A2 | METHOD FOR PRODUCING 1,3-HETEROAROMATIC CARBONATES | PROIONIC PRODUCTION OF IONIC SUBSTANCES GMBH & CO KEG (AT) | 2008-05-08 | — | — | WO | disclosed |
| US-4097580-A | FUNGICIDES, BACTERICIDES, VIRICIDES | UNIROYAL, INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-4004018-A | FUNGICIDES, BACTERICIDES, VIRICIDES | UNIROYAL INC. (US) | 1977-01-18 | — | — | US | disclosed |